Kawasaki syndrome (adult form) - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Adult Kawasaki Syndrome – Comprehensive Guide

Adult Kawasaki Syndrome – A Complete Medical Guide

Overview

Kawasaki syndrome (KS), also called Kawasaki disease (KD), is an acute, self‑limited vasculitis that predominantly affects medium‑sized arteries, especially the coronary arteries. While it is classically described as a pediatric illness (most cases occur in children <5 years old), 1–5 % of patients are adults, and the condition can present with a slightly different pattern and greater risk of cardiac complications.

Who it affects: Adults of any sex or ethnicity can develop KS, but most reported adult cases are in individuals of Asian descent (particularly Japanese and Korean) and in young adults (18–35 years). Women appear slightly more often affected than men (≈55 % vs. 45 %).

Prevalence: In the United States, the overall incidence of Kawasaki disease is about 19 per 100,000 children under 5 years (CDC, 2023). Adult cases are rare—estimated at 0.1–0.3 per 100,000 adults per year—so many physicians may never encounter it in practice.

Symptoms

Adult Kawasaki syndrome typically presents with a combination of the “classic” pediatric criteria plus adult‑specific features. At least 4 of the 5 principal criteria (or “incomplete” KD with coronary involvement) are needed for a diagnosis.

Principal clinical criteria

  • Fever lasting ≥5 days – high, often >39 °C (102 °F), refractory to antipyretics.
  • Bilateral conjunctival injection – non‑purulent redness of both eyes without exudate.
  • Oral mucosal changes – “strawberry tongue,” diffuse erythema of the lips and oral cavity, fissured lips.
  • Peripheral extremity changes – erythema of the palms/soles, edema, followed by periungual desquamation (peeling) 2–3 weeks after onset.
  • Polymorphous rash – can be maculopapular, erythema multiforme‑like, or scarlatiniform; often spares the face.
  • Cervical lymphadenopathy – usually unilateral, >1.5 cm, tender.

Additional adult‑specific findings

  • Arthralgia or migratory polyarthritis (knees, ankles, wrists).
  • Myalgias and severe fatigue.
  • Chest discomfort or atypical angina due to coronary artery inflammation.
  • Peripheral neuropathy or sensory changes (rare).
  • Gastrointestinal symptoms – abdominal pain, vomiting, or diarrhea, sometimes mimicking an acute abdomen.

Red‑flag features that suggest coronary involvement

  • Sudden onset chest pain, pressure, or shortness of breath.
  • Palpitations, syncope, or presyncope.
  • New heart murmur or abnormal ECG changes.

Causes and Risk Factors

The exact trigger for Kawasaki syndrome remains unknown, but prevailing theories point to an abnormal immune response to an infectious or environmental agent in genetically predisposed individuals.

Potential causes

  • Infectious agents – viral (e.g., adenovirus, coronavirus, RSV) or bacterial (Staphylococcus, Streptococcus) infections have been observed preceding KS in 30–40 % of cases, suggesting a post‑infectious immune activation.
  • Genetic susceptibility – specific HLA alleles (e.g., HLA‑B*15:02) and polymorphisms in immune‑regulating genes (e.g., ITPKC, CASP3) increase risk.
  • Environmental triggers – seasonal peaks (winter–early spring) and higher incidence in urban areas hint at environmental contributors.

Risk factors for adults

  • Asian ethnicity (especially Japanese, Korean, Chinese).
  • Family history of Kawasaki disease or other autoimmune vasculitides.
  • Recent respiratory or gastrointestinal infection.
  • Age 18–35 years (peak incidence); however, cases up to 70 years have been reported.
  • Smoking and uncontrolled hypertension may worsen vascular inflammation, though they are not primary causes.

Diagnosis

Because adult KD is rare, diagnosing it relies on careful clinical assessment, exclusion of mimicking conditions, and targeted investigations.

Clinical criteria

Presence of fever ≥5 days plus ≥ 4 of the 5 principal criteria, or fever ≥5 days with coronary artery abnormalities on imaging, qualifies as classic KD.

Laboratory findings (non‑specific but supportive)

  • Elevated inflammatory markers: C‑reactive protein (CRP) > 3 mg/dL, erythrocyte sedimentation rate (ESR) > 40 mm/h.
  • Leukocytosis with neutrophil predominance.
  • Thrombocytosis (platelets > 450 × 10⁹/L) after day 7.
  • Mild normocytic anemia, hypoalbuminemia, elevated liver enzymes (AST/ALT).
  • Urine: sterile pyuria (white cells without bacteria) in up to 30 % of adults.

Imaging and cardiac evaluation

  • Echocardiography – first‑line; assesses coronary artery dimensions, aneurysms, and ventricular function.
  • Cardiac MRI or CT angiography – for detailed coronary anatomy when echo is equivocal.
  • Electrocardiogram (ECG) – may show ST‑segment changes, arrhythmias, or prolonged QT.
  • Chest X‑ray – to rule out pneumonia or other acute thoracic causes of fever.

Differential diagnosis

Conditions that mimic adult KD include toxic shock syndrome, viral exanthems (measles, adenovirus), drug hypersensitivity reactions, systemic lupus erythematosus, and bacterial sepsis. Excluding these is essential before confirming KD.

Treatment Options

Prompt therapy (ideally within the first 10 days of fever) dramatically lowers the risk of coronary aneurysms—from ~25 % to <5 %.

First‑line therapy

  • Intravenous immunoglobulin (IVIG) – 2 g/kg as a single infusion over 10–12 hours. Reduces inflammation and inhibits antibody‑mediated damage.
  • Aspirin – High‑dose (80–100 mg/kg/day) during the acute phase until fever resolves, then low‑dose (3–5 mg/kg/day) for antiplatelet effect, continued for at least 6–8 weeks or longer if coronary aneurysms persist.

Adjunctive / second‑line agents (for IVIG‑resistant cases)

  • Second dose of IVIG (1 g/kg) if fever persists >36 h after the first dose.
  • Corticosteroids – Methylprednisolone 2 mg/kg/day IV, then taper; recommended for high‑risk patients (e.g., age > 40, high CRP, early coronary changes).
  • Biologic agents – Tumor necrosis factor‑α inhibitor (Infliximab 5 mg/kg) or anakinra (IL‑1 receptor antagonist) for refractory disease.
  • Plasma exchange – Rarely used, reserved for life‑threatening inflammation unresponsive to above measures.

Long‑term management

  • Low‑dose aspirin or, if aspirin contraindicated, clopidogrel 75 mg daily.
  • Statins (e.g., atorvastatin 10–20 mg) for patients with persistent coronary abnormalities, even without hyperlipidemia, due to anti‑inflammatory properties.
  • Regular cardiology follow‑up with serial echocardiograms at 2 weeks, 6 weeks, 6 months, and then annually if aneurysms persist.

Living with Kawasaki syndrome (adult form)

While most adults recover fully, those with coronary changes need ongoing care.

Daily management tips

  • Medication adherence – Never miss aspirin or prescribed anticoagulants; set daily alarms.
  • Heart‑healthy lifestyle – Balanced diet rich in omega‑3 fatty acids, regular aerobic exercise (150 min/week), weight control, and smoking cessation.
  • Stress reduction – Chronic inflammation can flare with stress; practice mindfulness, yoga, or counseling.
  • Vaccinations – Keep flu and COVID‑19 vaccines up to date; IVIG may blunt response, so vaccinate before treatment when possible.
  • Travel considerations – Carry a medical alert card stating “History of Kawasaki disease – on aspirin.” Avoid high‑altitude or extreme exertion if coronary aneurysms are present until cleared by a cardiologist.
  • Pregnancy – Women with prior KD can generally have safe pregnancies, but require close cardiac monitoring; low‑dose aspirin is usually continued.

Follow‑up schedule

  1. First cardiology visit within 2 weeks of discharge.
  2. Repeat echocardiogram at 6 weeks, 6 months, and then yearly if no coronary lesions.
  3. If aneurysms are present, cardiology may recommend stress testing or coronary CT angiography every 1–2 years.

Prevention

Because the exact trigger is unknown, primary prevention is limited. However, general measures can reduce the likelihood of the disease developing or recurring.

  • Prompt treatment of infections – Seek care for persistent fevers, especially after upper respiratory or gastrointestinal illnesses.
  • Maintain good oral hygiene – Reduces bacterial load that could act as a trigger.
  • Avoid smoking – Smoking worsens vascular inflammation.
  • Vaccination – Reduces incidence of viral infections that might precipitate an abnormal immune response.
  • Family screening – If a first‑degree relative had Kawasaki disease, inform your healthcare provider; early recognition can be lifesaving.

Complications

If untreated or inadequately treated, Kawasaki syndrome can lead to serious, sometimes life‑threatening complications.

  • Coronary artery aneurysms (CAA) – Occur in up to 25 % of untreated adults; can thrombose, cause myocardial infarction, or lead to sudden cardiac death.
  • Myocarditis – Inflammation of the heart muscle, presenting with chest pain, reduced ejection fraction.
  • Valvular disease – Rarely, aortic or mitral valve regurgitation due to inflammatory damage.
  • Peripheral artery stenosis – May cause limb ischemia.
  • Neurologic sequelae – Irritability, aseptic meningitis, or sensorineural hearing loss (more common in children but reported in adults).
  • Gastrointestinal perforation or pancreatitis – From severe vasculitis of mesenteric vessels.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

  • Sudden, severe chest pain or pressure that does not improve with rest.
  • Shortness of breath, wheezing, or feeling unable to catch your breath.
  • New onset palpitations, fainting, or near‑fainting spells.
  • Rapidly worsening fever (>39.5 °C / 103 °F) despite IVIG and high‑dose aspirin.
  • Swelling or severe pain in the arms/legs accompanied by color change (possible arterial thrombosis).
  • Persistent vomiting or severe abdominal pain, especially if accompanied by a rigid abdomen (possible perforation).

These signs may indicate coronary artery thrombosis, myocardial infarction, or other life‑threatening complications that require immediate medical intervention.

References

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References